These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 31941015)

  • 41. Autophagy and Mitochondria in Obesity and Type 2 Diabetes.
    Sarparanta J; García-Macia M; Singh R
    Curr Diabetes Rev; 2017; 13(4):352-369. PubMed ID: 26900135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study.
    Kim TN; Park MS; Lim KI; Choi HY; Yang SJ; Yoo HJ; Kang HJ; Song W; Choi H; Baik SH; Choi DS; Choi KM
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):525-32. PubMed ID: 22563924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autophagy in metabolic disease and ageing.
    Kitada M; Koya D
    Nat Rev Endocrinol; 2021 Nov; 17(11):647-661. PubMed ID: 34508250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes.
    Abderrahmani A; Yengo L; Caiazzo R; Canouil M; Cauchi S; Raverdy V; Plaisance V; Pawlowski V; Lobbens S; Maillet J; Rolland L; Boutry R; Queniat G; Kwapich M; Tenenbaum M; Bricambert J; Saussenthaler S; Anthony E; Jha P; Derop J; Sand O; Rabearivelo I; Leloire A; Pigeyre M; Daujat-Chavanieu M; Gerbal-Chaloin S; Dayeh T; Lassailly G; Mathurin P; Staels B; Auwerx J; Schürmann A; Postic C; Schafmayer C; Hampe J; Bonnefond A; Pattou F; Froguel P
    Diabetes; 2018 Jul; 67(7):1310-1321. PubMed ID: 29728363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obstructive Sleep Apnea Syndrome and Metabolic Diseases.
    Li M; Li X; Lu Y
    Endocrinology; 2018 Jul; 159(7):2670-2675. PubMed ID: 29788220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitochondrial dysfunction in metabolic syndrome.
    Prasun P
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165838. PubMed ID: 32428560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A High-Fat Diet Induces Muscle Mitochondrial Dysfunction and Impairs Swimming Capacity in Zebrafish: A New Model of Sarcopenic Obesity.
    Zou YY; Chen ZL; Sun CC; Yang D; Zhou ZQ; Xiao Q; Peng XY; Tang CF
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sarcopenic Obesity and Amino Acids: Concord Health and Ageing in Men Project.
    Le Couteur DG; Handelsman DJ; Stanaway F; Waite LM; Blyth FM; Naganathan V; Cumming RG; Hirani V
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1000-1004. PubMed ID: 33709116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
    Ramalingam L; Menikdiwela K; LeMieux M; Dufour JM; Kaur G; Kalupahana N; Moustaid-Moussa N
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1106-1114. PubMed ID: 27497523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
    Koliaki C; Roden M
    Mol Cell Endocrinol; 2013 Oct; 379(1-2):35-42. PubMed ID: 23770462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.
    Koliaki C; Szendroedi J; Kaul K; Jelenik T; Nowotny P; Jankowiak F; Herder C; Carstensen M; Krausch M; Knoefel WT; Schlensak M; Roden M
    Cell Metab; 2015 May; 21(5):739-46. PubMed ID: 25955209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review.
    Li CW; Yu K; Shyh-Chang N; Jiang Z; Liu T; Ma S; Luo L; Guang L; Liang K; Ma W; Miao H; Cao W; Liu R; Jiang LJ; Yu SL; Li C; Liu HJ; Xu LY; Liu RJ; Zhang XY; Liu GS
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):781-794. PubMed ID: 35106971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oxidative stress in adipose tissue as a primary link in pathogenesis of insulin resistance].
    Kuzmenko DI; Udintsev SN; Klimentyeva TK; Serebrov VY
    Biomed Khim; 2016; 62(1):14-21. PubMed ID: 26973182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overweight and obesity: the pathogenesis of cardiometabolic risk.
    Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
    Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
    Achari AE; Jain SK
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
    Wijarnpreecha K; Panjawatanan P; Aby E; Ahmed A; Kim D
    Maturitas; 2019 Jun; 124():48-54. PubMed ID: 31097179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
    Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.